Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Seizures × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 42 Breast Neoplasms 22 Stomach Neoplasms 21 Colorectal Neoplasms 21 Neoplasms 16 Esophageal Squamous Cell Carcinoma 12 Neoplasm Metastasis 11 Lung Neoplasms 11 Nasopharyngeal Carcinoma 10 Rectal Neoplasms 9 Colonic Neoplasms 7 Pancreatic Neoplasms 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Osteosarcoma 5 Brain Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Ovarian Neoplasms 4 Glioblastoma 4 Gastrointestinal Neoplasms 4 Precision Cell Immunotherapy 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Diseases 3 Digestive System Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Hepatocellular 3

Interventions

Temozolomide 1 Standard of Care 1 Medical Marijuana 1 Drug Therapy 1 Aspirin 1 Anticonvulsants 1 Airway Extubation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04450160 2020-06-29

AEO

MetVital, Inc.

Phase 2 Unknown

Glioblastoma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡